Guselkumab Adds PsA Structural Damage Inhibition to Label

Guselkumab is the only IL-23 inhibitor that has been proven to help stop further structural damage in patients with active psoriatic arthritis.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/guselkumab-adds-psoriatic-arthritis-structural-damage-2026a1000i12?src=rss

Author :

Publish date : 2026-05-29 17:39:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Guselkumab Adds PsA Structural Damage Inhibition to Label

Reassuring Data for Two High-Efficacy MS Meds in Pregnancy

Here’s Everything Wrong With the Offshore Ebola Quarantine Plan

Related Posts

Paid Parental Leave for Med School Faculty Often Lacking

Returned Travelers: Could More Than Souvenirs Come Home?

PPE failures left NHS staff poorly protected and wasted billions, Covid inquiry finds

SMC Accepts First Drug to Improve Survival in Uveal Melanoma

Woman’s Hour – ADHD and hormones, When co-habiting couples separate, God of War

How deadly have the heatwaves in England and Wales been?

Paid Parental Leave for Med School Faculty Often Lacking

Returned Travelers: Could More Than Souvenirs Come Home?

PPE failures left NHS staff poorly protected and wasted billions, Covid inquiry finds

SMC Accepts First Drug to Improve Survival in Uveal Melanoma

Woman’s Hour – ADHD and hormones, When co-habiting couples separate, God of War

How deadly have the heatwaves in England and Wales been?

Anemia Leads List of Factors That Affect BLVR Failure

Finding the Mystery to Trigger-Induced Atrial Fibrillation

Categories

Archives